FIELD: medicine.
SUBSTANCE: invention can be used for prevention of postoperative complications in combined treatment of patients suffering stage III non-small-cell lung cancer (NSCLC). A method contains intravenous introduction for 7-10 preoperative days of neotone 4 g once a day, mildronate 1 g once a day and mexidol 0.25 g two times a day.
EFFECT: use of the invention provides higher clinical effectiveness of stage III NSCLC ensured by reduced rate of postoperative cardiac complications.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF COMBINATION TREATMENT OF STAGE IIIA-IIIB LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER | 2010 |
|
RU2431450C1 |
| METHOD OF COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER OF II AND III STAGE | 2011 |
|
RU2455986C1 |
| METHOD OF PREMEDICATION IN PRE-OPERATION CHEMICAL THERAPY IN PATIENTS WITH NON-SMALL CELL III STAGE LUNG CARCINOMA | 2009 |
|
RU2397758C1 |
| METHOD FOR PREVENTION OF OSTEOPOROSIS ACCOMPANYING PREOPERATIVE CHEMOTHERAPY IN PATIENTS SUFFERING STAGE III NON-SMALL-CELL LUNG CANCER | 2010 |
|
RU2452483C1 |
| COMBINATION THERAPY OF LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2372901C2 |
| METHOD OF COMBINED TREATMENT OF NON-SMALL CELL CANCER OF LUNG OF III STAGE | 2007 |
|
RU2340336C1 |
| METHOD OF COMBINED TREATMENT OF LUNG CANCER STAGE III | 2007 |
|
RU2348440C2 |
| METHOD OF TREATMENT OF PATIENTS WITH LOCAL NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2361580C2 |
| METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
| METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OPERABLE OESOPHAGEAL CANCER | 2009 |
|
RU2424007C1 |
